Sencilia has been gaining traction on the market, and has been the recipient of several awards and competitive Dutch and European grants since its inception.
Stay tuned for updates as we continue on our mission to make IV infusion therapy safer for patients!
We are happy to share that Sencilia has been chosen to be one of the...
We are thrilled to announce the successful funding of our project 'SmartInfuus' in collaboration with...
A world-renowned clinical expert in neonatal vascular access, Roland's reputation as a researcher and nursing...
IMPORTANT NOTICE: Rely-V® is an investigational technology currently under development and pre-clinical evaluation. It is not a certified medical device, not CE-marked or FDA-approved, and not available for clinical use or sale. The technology may not be used in any clinical setting. All descriptions reflect our development objectives and are subject to regulatory approval and clinical validation. The information presented is intended for research partners, potential investors, and other interested parties only.
